[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE165363T1 - Verfahren und mittel zur sortierung und bestimmung biologischer informationen - Google Patents

Verfahren und mittel zur sortierung und bestimmung biologischer informationen

Info

Publication number
ATE165363T1
ATE165363T1 AT86905604T AT86905604T ATE165363T1 AT E165363 T1 ATE165363 T1 AT E165363T1 AT 86905604 T AT86905604 T AT 86905604T AT 86905604 T AT86905604 T AT 86905604T AT E165363 T1 ATE165363 T1 AT E165363T1
Authority
AT
Austria
Prior art keywords
sorting
biological information
population
determining biological
length
Prior art date
Application number
AT86905604T
Other languages
English (en)
Inventor
George Pieczenik
Original Assignee
George Pieczenik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Pieczenik filed Critical George Pieczenik
Application granted granted Critical
Publication of ATE165363T1 publication Critical patent/ATE165363T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT86905604T 1985-08-28 1986-08-28 Verfahren und mittel zur sortierung und bestimmung biologischer informationen ATE165363T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77039085A 1985-08-28 1985-08-28

Publications (1)

Publication Number Publication Date
ATE165363T1 true ATE165363T1 (de) 1998-05-15

Family

ID=25088390

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86905604T ATE165363T1 (de) 1985-08-28 1986-08-28 Verfahren und mittel zur sortierung und bestimmung biologischer informationen

Country Status (6)

Country Link
EP (1) EP0241487B1 (de)
AT (1) ATE165363T1 (de)
AU (1) AU626252B2 (de)
DE (1) DE3650676T2 (de)
IL (1) IL79881A (de)
WO (1) WO1987001374A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US7413537B2 (en) 1989-09-01 2008-08-19 Dyax Corp. Directed evolution of disulfide-bonded micro-proteins
FR2656626B1 (fr) * 1989-12-29 1994-08-12 Pasteur Institut Fragment peptidique comprenant une sequence issue de la proteine 28 kda de schistosoma mansoni et compositions vaccinantes et/ou therapeutiques comprenant ledit fragment.
US5814460A (en) * 1990-02-14 1998-09-29 Diatide, Inc. Method for generating and screening useful peptides
US5366862A (en) * 1990-02-14 1994-11-22 Receptor Laboratories, Inc. Method for generating and screening useful peptides
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
EP1279731B1 (de) 1991-03-01 2007-05-30 Dyax Corporation Verfahren zur Herstellung bindender Miniproteine
US5747253A (en) * 1991-08-23 1998-05-05 Isis Pharmaceuticals, Inc. Combinatorial oligomer immunoabsorbant screening assay for transcription factors and other biomolecule binding
AU2547592A (en) * 1991-08-23 1993-03-16 Isis Pharmaceuticals, Inc. Synthetic unrandomization of oligomer fragments
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5733731A (en) * 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US6448373B1 (en) 1994-01-11 2002-09-10 Isis Pharmaceuticals, Inc. Phosphate linked oligomers formed of monomeric diols and processes for preparing same
US6828427B1 (en) 1994-01-11 2004-12-07 Isis Pharmaceuticals, Inc. Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same
US6184389B1 (en) 1994-01-11 2001-02-06 Isis Pharmaceuticals, Inc. Combinatorial libraries having aminodiol monomer subunits
WO1999031270A1 (fr) * 1997-12-15 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Tri par hybridation numerique
US6248541B1 (en) 2000-04-21 2001-06-19 Genencor International, Inc. Screening under nutrient limited conditions
US6534292B1 (en) 2000-05-08 2003-03-18 Genencor International, Inc. Methods for forming recombined nucleic acids
US6582914B1 (en) 2000-10-26 2003-06-24 Genencor International, Inc. Method for generating a library of oligonucleotides comprising a controlled distribution of mutations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD143794A1 (de) * 1979-06-01 1980-09-10 Liebscher Dirck Hartmut Verfahren zur isolierung langer doppelstrang-cdns-molekuele aus einer heterogenen population
JPS57129691A (en) * 1980-09-22 1982-08-11 Yunibaashiteii Obu Sazan Karif Rearranged dna active in nuclear cell and preparation thereof
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4503142A (en) * 1982-06-25 1985-03-05 Litton Bionetics, Inc. Open reading frame vectors
DE3300632A1 (de) * 1982-12-13 1984-07-12 Christian Dipl.-Ing. 8900 Augsburg Strobel Verfahren genetischer analyse und synthese
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
AU576750B2 (en) * 1983-03-08 1988-09-08 Chiron Mimotopes Pty Ltd Method of determining antigenically active amino acid sequences
PH21409A (en) * 1983-07-21 1987-10-15 Scripps Clinic Res Synthetic polypeptides and pharmaceutical composition containing the same
DE3328832A1 (de) * 1983-08-10 1985-02-28 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Reagenz und verfahren zur quantitativen bestimmung von antikoerpern
CA1219232A (en) * 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
EP0154186B1 (de) * 1984-02-10 1992-07-22 Cytoclonal Pharmaceutics Inc. Isolierung eines Interferongens und Expression desselben
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
ATE81722T1 (de) * 1984-07-24 1992-11-15 Coselco Mimotopes Pty Ltd Verfahren zur bestimmung von mimotopen.

Also Published As

Publication number Publication date
WO1987001374A2 (en) 1987-03-12
AU626252B2 (en) 1992-07-30
DE3650676D1 (de) 1998-05-28
EP0241487A1 (de) 1987-10-21
IL79881A0 (en) 1986-11-30
DE3650676T2 (de) 1998-09-17
AU6338086A (en) 1987-03-24
EP0241487B1 (de) 1998-04-22
WO1987001374A3 (en) 1987-05-21
IL79881A (en) 1995-12-08

Similar Documents

Publication Publication Date Title
DE3650676D1 (de) Verfahren und mittel zur sortierung und bestimmung biologischer informationen
DE68907407D1 (de) Verfahren zur sequenzanalyse von dna.
IL96907A0 (en) Proteins produced by human lymphocytes,a dna sequence coding for said proteins and their pharmaceutical and biological application
DE69006306D1 (de) Synthetische peptide des konjugates von ubiquitin und histon h2a.
DE58908694D1 (de) Oligonucleotidbank und verfahren zur dna-sequenzierung.
DE3854334D1 (de) Verfahren und Gerät zur Bestimmung von Substanzen.
DE68903884D1 (de) Mittel und methode zur bestimmung von spurenmengen an proteinen.
DE69433934D1 (de) Verfahren und Zusammensetzungen zur erhöhten Proteinproduktion von rekombinanter DNA
DE69407638D1 (de) Verfahren zur Fraktionierung von Blutmaterial
DE69002937D1 (de) Material und verfahren zur sauerstoffabtastung.
DE3687103D1 (de) Verfahren zur herstellung von n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline.
DE69822307D1 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
DE3863285D1 (de) Verfahren und reagenz zur bestimmung von persaeuren.
SE8801701D0 (sv) Production technology based on enzymic method
DE3587875D1 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
DE3874623D1 (de) Analytisches verfahren und element fuer eine proteinprobe.
DE3668068D1 (de) Mittel und verfahren zur bestimmung von calcium.
DE68917273D1 (de) Testmethode und Gerät zur Bestimmung des gesamten Proteins.
DE68914372D1 (de) Verfahren und Ausrüstung zur Identifizierung von DNS-Basen.
DE69010155D1 (de) Verfahren zur Trennung von Aminosäuren.
SE9002212D0 (sv) Igg binding protein
DE68906932D1 (de) Verfahren zur reinigung und isolierung carboxyl-endstaendiger peptide.
DE3584029D1 (de) Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
DE3882411D1 (de) Verfahren zur trennung von aktiviertem menschlichem protein c.
AU4981093A (en) Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee